Biogen

Biogen's Controversial Alzheimer's Drug Withdrawn From Market

The FDA Approved a New Drug To Treat Alzheimer’s, but Medicare Won’t Always Pay for It – A Doctor Explains Biogen’s Aduhelm

FDA Commissioner Calls For Inspector General Probe Into Biogen Alzheimer’s Drug Approval

Biogen Exec Denies That New Alzheimer’s Medicine Will Overwhelm Medicare — But Experts Disagree

Third member of FDA advisory panel resigns over Alzheimer's drug approval - The resignations are in protest over the agency's decision to approve Biogen Inc's Alzheimer's treatment despite the committee's recommendation against doing so.

Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense

Alert: FDA Approves New Alzheimer's Drug From Biogen

FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades